Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Unveiling How Rotavirus Causes Infection

By R&D Editors | January 7, 2015

Source: University of Melbourne

Researchers from the University of Melbourne and Griffith University’s Institute for Glycomics have significantly advanced understanding of a virus that kills up to half a million children each year.

Rotaviruses are considered the most important cause of severe diarrhoea in children, with all being infected by the time they reach the age of five.

A paper published in the international journal Nature Communications reveals how the virus attacks cells through carbohydrate receptors present on a child’s intestinal cells.

Associate Professor Barbara Coulson, of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne and a co-senior author said the discovery has implications for childhood susceptibility to rotavirus disease.

“What we have found is that not all human rotaviruses recognise the same sugar receptor and this important information will be invaluable in the discovery of anti-rotaviral drugs,” she said.

Professor Mark von Itzstein, a co-senior author of the paper and Director of the Institute for Glycomics, said the study greatly assists the understanding of how this virus starts to infect cells and provides new direction in potential drug discovery.

“Our findings greatly advance our understanding of the sugar receptors used by human rotaviruses and provide clues as to how we might target this virus to stop it infecting cells,” he said.

Dr Thomas Haselhorst, an Australian Research Council Future Fellow at the Institute and a co-senior author on the paper, said the findings also offer potential for new vaccine development strategies.

“We are very excited by our findings, as we now have a much better understanding of the carbohydrates important for the virus to latch on to for successful infection.”

The multidisciplinary study was funded by The National Health and Medical Research Council and the Australian Research Council.

The Melbourne and Griffith team is now further advancing the work towards novel drug and vaccine development.

Source: University of Melbourne

Related Articles Read More >

Inhaled nitric oxide could help combat antibiotic resistance
Back view of a runner walking on a road in a park at dawn in summer in autumn.
Drug R&D is winning the battles it can. Walking and staying active help with the rest.
New engineered proteins could make disease tracking portable and precise
MIT team uses mysterious cell structure to record genetic activity
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE